Agoracom Blog Home

Archive for the ‘AGORACOM Via Satellite’ Category

« Older Entries
Newer Entries »

Lancaster’s CEO Targets “Company-Maker” Gold Discovery in Australia

Posted by Brittany McNabb at 8:27 PM on Monday, May 12th, 2025

HIGHLIGHTS:

  • Bonanza-Grade Upside: Historic samples up to 204 g/t gold at Lake Cargelligo in Australia’s prolific Cobar Mining District.
  • Next-Gen Exploration: AI-powered targeting and modern geophysics set to unlock previously missed zones in Q3 2025.
  • Multi-Commodity Growth: Exposure to gold, uranium (Athabasca Basin), and lithium (James Bay & New Mexico).
  • Leadership That Delivers: New CEO Andrew Watson brings a capital-efficient strategy backed by a veteran technical team with global discovery success.

In a year when gold just hit an all-time high of $3,430 USD ($4,700 CAD) per ounce, Lancaster Resources is positioning itself squarely at the intersection of market momentum and strategic resource acquisition. The company has secured the Lake Cargelligo project in New South Wales — a 287 sq. km property in the proven but underexplored Cobar Mining District.

CEO Andrew Watson, newly appointed to lead the company through its next phase of growth, calls the project “a potential company-maker” — and not without reason. With historic bonanza-grade samples up to 204 g/t gold and multiple zones of mineralization identified over a 25 km strike length, Lancaster believes it’s targeting the kind of scale that has delivered multi-million-ounce discoveries in the past.

“Lake Cargelligo checks all the boxes: a tier-one mining jurisdiction, historic high-grade samples, and zero modern geophysics. We believe it holds the scale potential of a Fort Knox-style discovery.” – Andrew Watson, CEO, Lancaster Resources

DISTRICT SCALE POTENTIAL

Lake Cargelligo offers district-scale potential in a gold-producing region that already hosts mines with resources exceeding 1.7 million ounces. Lancaster Resources is preparing to deploy next-generation geophysics and AI-powered targeting technologies, aiming to identify mineralized zones that were missed during earlier, shallow drilling campaigns.

To strengthen its exploration program, the company has engaged two seasoned Australian geologists — Ross Brown, with over 40 years of global exploration experience, and Rob Heaslop, known for his operational depth and discovery track record.

STRATEGIC DEPTH: MORE THAN JUST GOLD

While gold remains Lancaster’s near-term focus, the company is building long-term strategic depth across multiple critical commodities. It holds two uranium properties in Canada’s Athabasca Basin — the world’s top uranium district — positioning it to benefit from rising energy demand driven by AI and electrification.

Additionally, its lithium portfolio includes brine assets in New Mexico and hard-rock claims in Quebec’s James Bay region, offering exposure to the growing need for energy storage solutions.

CONCLUSION

Lancaster’s portfolio is aligned with three of the strongest commodity trends in the global market today: gold, uranium, and lithium. With near-term exploration at Lake Cargelligo set to begin in Q3 2025, and a veteran technical team in place, Lancaster is emerging as a compelling small cap to watch.

Tags: , , ,
Posted in AGORACOM Via Satellite, All Recent Posts | Comments Off on Lancaster’s CEO Targets “Company-Maker” Gold Discovery in Australia

Renforth Resources Confirms 363,000 Ounces of Gold Beside Canada’s Largest Gold Mine

Posted by Brittany McNabb at 12:25 PM on Thursday, April 17th, 2025

A Major Step Forward for a Junior Explorer With Proven Vision

In a landscape where small-cap mining companies often struggle to produce meaningful results, Renforth Resources (CSE: RFR | OTC: RFHRF | FSE: 9RR) has just delivered a development that could significantly shift its standing in the gold sector.

In an exclusive interview, CEO Nicole Brewster confirmed a 29% increase in the gold resource at the company’s flagship Parbec Gold Deposit in Quebec. This brings the total to 363,000 ounces of gold, of which 265,000 ounces are now classified as Measured and Indicated—a substantial upgrade in confidence and quality. Notably, 12% of the total ounces are in the Measured category, and 87% of the ounces are within a Whittle pit shell, underscoring the deposit’s open-pit viability and potential economic value.

All of this is happening next door to Agnico Eagle’s Canadian Malartic Mine, one of the largest and most productive gold operations in the country.

Why This Matters: Grade, Location, and Optionality

Renforth’s Parbec project lies on the prolific Cadillac Break, a structure responsible for over 100 million ounces of historical gold production in Canada. Yet Parbec is no mere geological curiosity. It is:

  • Surface-exposed and fully road-accessible;
  • Situated beside Canada’s largest open-pit gold mine;
  • Host to infrastructure including a historic underground ramp;
  • Surrounded by multiple toll-milling facilities operated by Agnico Eagle and other major producers;
  • And now, significantly de-risked with its enhanced resource classification.

This strategic location puts Renforth in a rare position to benefit from regional processing demand.

“With this update, 73% of Parbec’s ounces are now in the Measured and Indicated categories,” said Brewster. “We consider Parbec a small-scale replica of Canadian Malartic — same geology, same break, similar surface profile.”

Flexible Pathways to Monetization

Renforth is not committing to a single development path. Instead, it is evaluating a range of monetization options:

  • Sale: Parbec’s location, ounces, and infrastructure make it an ideal bolt-on asset for a producer like Agnico Eagle, whose “fill-the-mill” strategy is now in full swing following acquisitions like the Marban project.
  • Joint Venture: Brewster confirmed the company has received partnership inquiries and could benefit from joint development.
  • Toll Milling / Bulk Sampling: If desired, Renforth could begin small-scale production through existing infrastructure, with low capex and minimal environmental footprint.

Further exploration could still add additional ounces, especially in areas beneath the current pit model and into the Pontiac sediments, where new gold-bearing structures have already been identified.

Macro Tailwinds: Gold’s Rise Aligns With Renforth’s Momentum

The timing of this update couldn’t be more strategic. Gold is trading above $3,200 USD per ounce, and many experts, including Brewster, expect it to remain above $3,000 throughout 2025, driven by central bank buying, geopolitical instability, and inflationary concerns.

Renforth’s latest resource estimate was calculated at $2,100 USD per ounce, suggesting further upside potential if gold prices hold or increase.

Internally, the company has already run sensitivity analyses using higher gold prices, which indicate more ounces could be captured in future updates.

The Bigger Picture: Strategic Fit in a Global Mining Corridor

Renforth’s Parbec project aligns neatly with a growing global emphasis on resource security and domestic development. With Canada reaffirming its role as a stable jurisdiction for mining, and gold once again capturing investor attention, Renforth has a credible, scalable project in a tier-one location.

Add in the exploration upside, established infrastructure, and multiple monetization options, and the result is a company with more than just potential — it has momentum.

Final Thoughts

In an industry where many juniors struggle to translate drill results into real-world opportunity, Renforth Resources has delivered what few others have: a tangible, credible, and increasingly valuable gold asset in one of the world’s most prolific mining jurisdictions.

The 363,000-ounce Parbec resource — 87% of it in an open-pit shell and 265,000 ounces in Measured and Indicated — isn’t just a milestone. It’s a statement.

And as Brewster concluded: “We’re in no rush. Time is on our side — and so is gold.”

Watch the full interview here: 

Tags: , , , ,
Posted in AGORACOM Via Satellite, Renforth Resources | Comments Off on Renforth Resources Confirms 363,000 Ounces of Gold Beside Canada’s Largest Gold Mine

This Small Cap Gold Company Announced 363,000 Ounces As Gold Sets Record Prices

Posted by Brittany McNabb at 4:38 PM on Tuesday, April 15th, 2025

In this interview with AGORACOM, Renforth Resources Inc. (CSE: RFR | OTCQB: RFHRF | FSE: 9RR) CEO Nicole Brewster discusses the company’s newly updated 2025 Mineral Resource Estimate for its 100%-owned Parbec Gold Deposit in Quebec — a move that significantly strengthens the company’s value proposition at a time when gold prices continue to surge. The updated estimate now totals 363,000 ounces of gold, marking a 29% increase over the previous figure and signaling growing maturity and confidence in the deposit. Notably, 265,000 ounces are now categorized as Measured and Indicated, and 87% of the total resource sits within an open pit — directly adjacent to Agnico Eagle’s Canadian Malartic Mine, one of Canada’s largest gold operations.

KEY HIGHLIGHTS: Open Pit Advantage: With mineralization starting at surface and a pit depth of 300 meters, Parbec’s economics are compelling, especially with nearby toll milling options. Strategic Fit for Agnico: The project’s location beside Canadian Malartic and proximity to multiple mills makes it a potential solution for Agnico Eagle’s “fill-the-mill” strategy — especially amid $5.6B in M&A activity in the district.

Clear Monetization Path: CEO Nicole Brewster outlines a three-path strategy: sale, joint venture, or self-development, including a plan to initiate stripping and bulk sampling this summer for potential cash flow.

A COMPELLING QUOTE FROM THE CEO “We are very happy to deliver this significant size increase to our open pit gold deposit next door to Agnico Eagle’s Canadian Malartic mine… With this MRE, 87% of the gold ounces within the resource estimate are contained within the accompanying open pit.” — Nicole Brewster, CEO

WHY INVESTORS SHOULD WATCH THIS INTERVIEW Renforth has done what many small caps struggle to achieve: increase its resource size while also upgrading confidence categories — all while controlling costs and maintaining 100% ownership in one of the world’s top-ranked mining jurisdictions. With strategic positioning next to Canada’s mining giant, viable paths to monetization, and growing relevance in a high-gold-price environment, Parbec is moving from potential to probability.

This interview isn’t just an update — it’s a real-time look into how Renforth is strategically unlocking value from its assets and evaluating serious next steps. Watch the full interview now to understand why Renforth could be a key player in Quebec’s next wave of gold development.

Tags: , , , , ,
Posted in AGORACOM Via Satellite, All Recent Posts, Renforth Resources | Comments Off on This Small Cap Gold Company Announced 363,000 Ounces As Gold Sets Record Prices

Kidoz Delivers Record Quarter WIth $10.7 Million In Revenue For Q4-24

Posted by Brittany McNabb at 11:04 AM on Thursday, April 10th, 2025

Kidoz Inc. (TSXV: KIDZ), the global leader in child-safe mobile advertising, just posted its strongest quarter to date—solidifying its position as the default monetization platform for digital content aimed at children under 13. 

With quarterly revenue hitting $10.7 million and a pre-tax profit of $2.9 million, the company not only returned to profitability but also showcased the strength of its privacy-first model in a rapidly evolving regulatory environment.

STRATEGIC GROWTH BACKED BY INDUSTRY GIANTS

Kidoz’s impressive growth is underpinned by key partnerships and widespread industry adoption:

  • Integrated into nearly 5,000 kid-focused apps
  • Reaches over 400 million monthly active users globally
  • Trusted by brands like Disney, LEGO, Mattel, McDonald’s, and Hasbro
  • Certified partner of Apple and Google

The company’s AI-powered contextual ad engine, which targets content—not personal behavior—is proving essential as tech platforms introduce tools to support age-appropriate experiences.

THE KID SAFE REGULATORY ADVANTAGE

As lawmakers tighten the rules around data privacy—particularly for children—Kidoz stands apart. The company is fully compliant with global standards like COPPA and GDPR-K and is already aligned with forthcoming legislation like COPPA 2.0, which will mandate age-gating and data separation for under-13 audiences.

“Unlike traditional ad networks, we don’t collect our profile user data. Our contextual AI targeting is designed from the ground up to protect kids’ privacy—and that’s become our biggest competitive advantage.”
— Jason Williams, CEO of Kidoz Inc.

LOOKING AHEAD: PROFITABILITY, SCALE & MARKET SHARE

Kidoz has committed to maintaining quarterly profitability throughout 2025. With regulators enforcing stricter data use policies and major brands seeking safe ad environments, the company is capturing a growing share of a market forecast to surpass $100 billion in digital ad spend.

With a clear regulatory tailwind, scalable technology, and a rapidly growing client base, Kidoz is not just adapting to change—it’s defining the future of child-focused digital advertising.

Tags: , , , ,
Posted in AGORACOM Via Satellite, Kidoz | Comments Off on Kidoz Delivers Record Quarter WIth $10.7 Million In Revenue For Q4-24

280,000 Ounces of Gold, Major Critical Minerals & Near $5.5B in M&A: Renforth’s Moment Is Here

Posted by Brittany McNabb at 12:48 PM on Thursday, April 3rd, 2025

Renforth Resources: Positioned for Gold and Critical Mineral Success in Quebec

In a compelling new interview with AGORACOM, Renforth Resources Inc. (CSE: RFR | OTCQB: RFHRF | FSE: 9RR) CEO Nicole Brewster laid out a clear and convincing case for why this Canadian junior exploration company is exceptionally well-positioned amid record gold prices and rising global demand for critical minerals. With flagship assets in Quebec’s world-renowned Abitibi mining district, Renforth is advancing both its 100%-owned Parbec Gold Deposit and the massive Malartic Metals Package — a combined landholding that sits in one of the richest and most active mining corridors in North America.

Strategic Location Beside Mining Giants

Renforth’s Parbec Gold Project is situated directly adjacent to Agnico Eagle’s Canadian Malartic Mine, the country’s largest open-pit gold mine. The deposit already contains 280,000 ounces of gold (101,000 oz indicated, 177,000 oz inferred), with a new NI 43-101 resource estimate expected soon. This update will include 15,000 metres of additional drilling and could significantly increase the gold resource, especially with current gold prices near C$4,500/oz.

The Parbec project benefits from exceptional infrastructure: direct road access, two hydroelectric lines crossing the property, nearby toll milling facilities, and close proximity to the Glencore-owned Horn Smelter. As Brewster puts it, “It can’t get cheaper than this — the economics of development in this region are simply unbeatable.”

Malartic Metals Package: A Critical Mineral Powerhouse

Located just north of Parbec, the 300 km² Malartic Metals Package hosts the emerging 20-kilometre-long Victoria nickel-sulphide polymetallic structure. Recent metallurgical results show that the mineralization — which includes nickel, zinc, copper, cobalt, and silver — is hosted in conventional sulphide minerals, indicating potential for standard, cost-effective processing.

Initial mineralogical analysis and TOMRA sorting tests demonstrate strong early signs of recoverability and grade optimization. Brewster also confirmed that Renforth is working with SGS to determine whether its current drilling supports a maiden resource — an important step toward unlocking value in this new discovery.

In the Midst of $5.6 Billion in M&A

Renforth is surrounded by major mining players. Agnico Eagle has spent billions acquiring and consolidating deposits across the Abitibi in recent years, including the Yamana and O3 Mining deals. Parbec sits right in the middle of this activity, offering both strategic value and expansion potential to any nearby operator looking to sustain mill throughput or grow their regional footprint.

“This is a proven gold deposit, sitting beside a mine that’s going underground and needs more ore. The strategic value is obvious,” Brewster stated.

Quebec Advantage: Cost, Policy, and Market Access

Renforth’s position in Quebec provides significant advantages beyond geology. The province is routinely ranked as a top-tier mining jurisdiction globally, and the Quebec government recently introduced new stimulus programs specifically aimed at accelerating critical mineral exploration. With access to hydroelectric power, deepwater ports, rail lines, and North America’s battery manufacturing corridor, Renforth’s assets are ideally situated to capitalize on emerging resource trends.

Conclusion: Value Waiting to Be Realized

Despite world-class assets, infrastructure, and jurisdictional advantages, Brewster noted that capital has been hard to come by for juniors — and that Renforth has instead prioritized drilling and science over promotional spending. “We’ve outlined real metals in the ground that aren’t going anywhere. What we’re building is real,” she said.

With a new gold resource estimate imminent, growing strategic relevance in the critical minerals space, and near-term catalysts ahead, Renforth Resources appears to be an underappreciated player in a district that continues to deliver major value.

For those seeking exposure to gold and critical minerals in one of the most mining-friendly regions in the world, Renforth may be one to watch.

Watch the full interview here: 

Tags: , , , ,
Posted in AGORACOM Sector Spotlight, AGORACOM Small Cap Stocks For Investment, AGORACOM Via Satellite, Renforth Resources | Comments Off on 280,000 Ounces of Gold, Major Critical Minerals & Near $5.5B in M&A: Renforth’s Moment Is Here

Canadian Biotech Quantum BioPharma Nears a Landmark Multiple Sclerosis Breakthrough

Posted by Brittany McNabb at 9:54 AM on Thursday, March 27th, 2025

New Approach Could Redefine How Multiple Sclerosis Is Treated Worldwide

Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) may be on the verge of redefining treatment for multiple sclerosis (MS), a chronic neurological disorder affecting nearly 3 million people worldwide. In a compelling interview on the AGORACOM, Dr. Andrzej Chruscinski, Vice-President of Scientific and Clinical Affairs at Quantum BioPharma, detailed the company’s successful completion of its Phase 1 clinical trial for Lucid-MS, a first-in-class neuroprotective drug targeting demyelination—the core driver of MS progression.

Unlike existing treatments, which primarily focus on managing the immune system and controlling inflammation, Lucid-MS takes aim at protecting and potentially repairing the myelin sheath—the protective layer around nerve cells that degenerates in MS patients. “We’re excited about the potential of Lucid-MS to protect myelin in MS patients as it represents a new direction in the treatment of this disease,” said Quantum BioPharma CEO Zeeshan Saeed.

A Novel Solution to a Persistent Problem

Most MS therapies today only address the inflammatory aspect of the disease, leaving the underlying neurodegeneration largely unaddressed. Lucid-MS changes that narrative.

  • The drug works by preventing the unraveling of the myelin sheath, a process triggered by a chemical modification known as citrullination.

  • Developed over a decade by Dr. Lakshmi Kotra and Dr. Mario Moscarello at the University of Toronto, Lucid-MS targets this key process, aiming to halt disease progression and protect nerve communication.

  • The approach has already shown success in preclinical animal models.

“Think of the myelin sheath like insulation around electrical wiring. When that’s compromised, signals can’t transmit properly,” explained Dr. Chruscinski. “Our drug preserves that insulation, maintaining neural function.”

Phase 1 Trial: Safety Confirmed, Therapeutic Potential Emerges

The recently completed Phase 1 trial focused on evaluating safety and pharmacokinetics in healthy participants. According to Dr. Chruscinski, “Lucid-MS was safe and well-tolerated, with no adverse events. We’re also pleased with the drug levels observed in blood, which we believe are therapeutic.”

This milestone is crucial for advancing to Phase 2, where the company will begin testing Lucid-MS in MS patients to assess efficacy.

What to Expect in Phase 2

The company is actively designing its Phase 2 trial with a projected start in Q1 2026, pending FDA clearance via an Investigational New Drug (IND) application in late 2025.

Key details under consideration:

  • The trial will include roughly 60 MS patients (30 receiving Lucid-MS and 30 on placebo).

  • Outcomes will be measured using MRI scans and clinical assessments to evaluate both biological and functional improvement.

  • While the exact location is yet to be confirmed, Quantum is exploring options to include Canadian sites in recognition of the drug’s Canadian origins.

Support From the Scientific Community

Feedback from global experts at major MS conferences in North America and Europe has been overwhelmingly positive. “The response has been tremendous,” said Dr. Chruscinski. “There’s a real appetite for a drug that targets neurodegeneration, which remains an unmet need in MS.”

This third-party validation underscores the broader scientific and commercial relevance of Quantum BioPharma’s work.

A Human-Centered Mission With Investor Appeal

Dr. Chruscinski also emphasized his personal motivation. “It’s exciting to be part of something that could make a real difference. I was there when the first dose was administered in our Phase 1 trial. That’s a moment I won’t forget.”

While the drug development process remains long and complex, Quantum BioPharma has achieved a significant milestone that positions the company—and Lucid-MS—at the forefront of innovation in MS treatment.

For investors, the opportunity lies in Quantum’s unique approach, successful early data, and a clearly defined path toward a potential market-shifting solution.

Conclusion: A Meaningful Milestone With a Promising Horizon

With a Phase 1 trial successfully completed and a novel therapeutic mechanism unlike anything currently on the market, Quantum BioPharma is emerging as a company to watch in the fight against multiple sclerosis. As it gears up for its Phase 2 trial and FDA engagement, the company stands at a pivotal inflection point—one that could not only deliver long-term value for investors but also reshape the future of MS care.

To hear Dr. Chruscinski explain the science, milestones, and next steps in his own words, watch the full interview here: 

Tags: , , , , ,
Posted in AGORACOM Client Feature, AGORACOM Sector Spotlight, AGORACOM Small Cap Stocks For Investment, AGORACOM Via Satellite, All Recent Posts, Quantum BioPharma Ltd. | Comments Off on Canadian Biotech Quantum BioPharma Nears a Landmark Multiple Sclerosis Breakthrough

Canadian Small Cap Quantum BioPharma on The Verge of Multiple Sclerosis Breakthrough

Posted by Brittany McNabb at 5:01 PM on Tuesday, March 25th, 2025

KEY MILESTONES AND WHAT’S NEXT

  • Successful Phase 1 Trial: Lucid-MS has shown excellent safety with no serious side effects, paving the way for a groundbreaking treatment for MS.
  • Next Major Step: The Phase 2 trial is set for early 2026, with 60 participants.
  • FDA Submission on the Horizon: Plans to submit application to the FDA by late 2025, taking a huge step toward regulatory approval.
  • Massive Market Opportunity: With 2.9 million people worldwide affected by Multiple Sclerosis and the market projected to surpass $30 billion by 2030, Lucid-MS could potentially capture a significant share of this rapidly expanding space.

A NEW ERA IN MULTIPLE SCLEROSIS TREATMENT

Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Lucid-MS is setting the stage to revolutionize MS treatment. Unlike existing therapies that only target immune system responses, Lucid-MS focuses on protecting and repairing myelin, the critical layer around nerve fibers. This novel approach has the potential to slow or even reverse disease progression—offering new hope for millions of MS sufferers.

HOW DOES IT WORK? A TOTALLY NEW APPROACH TO TREATING MS

Think of nerves like electrical wires in your body, and myelin as the protective coating around those wires. With Multiple Sclerosis, the immune system attacks this coating (called demyelination), causing damage that leads to muscle weakness, vision problems, and difficulty moving.

Most MS treatments try to calm the immune system to slow down the attack. Lucid-MS is different. Instead of focusing on the immune system, it works directly on the myelin to stabilize and protect it from damage.

WHY IS THIS IMPORTANT?

By keeping myelin intact, Lucid-MS may help slow down the progression of MS and prevent disability—something current MS drugs don’t do very well.

SCIENTIFIC BREAKTHROUGH BACKED BY INDUSTRY RECOGNITION

Lucid-MS is backed by cutting-edge research from Dr. Lakshmi Khotra’s lab at the University of Toronto, where the critical process of myelin breakdown in MS patients was discovered. The drug’s ability to address this underlying issue is a potential game-changer in neurodegenerative treatments.

It’s already gaining enthusiastic support from leading medical experts and researchers, underscoring its transformative potential.

A VISION FOR THE FUTURE

Dr. Andrzej Chruscinski, Vice President of Scientific and Clinical Affairs at Quantum BioPharma, expressed the company’s excitement about Lucid-MS’s future.

“We are on the cusp of something monumental. Lucid-MS has the potential to transform MS treatment and open doors for treating other nerve-related diseases. As we move toward Phase 2 and beyond, we’re excited to bring this innovative therapy to the patients who need it most.”

With promising clinical results, a massive market opportunity, and rising industry recognition, Quantum BioPharma is leading the charge in next-generation treatments for Multiple Sclerosis 

YOUR NEXT $QNTM STEPS

$QNTM HUB On AGORACOM: https://agoracom.com/ir/Quantumbiopharma $QNTM 5 Minute Research Profile On AGORACOM: https://agoracom.com/ir/Quantumbiopha… $QNTM Official Verified Discussion Forum On AGORACOM: https://agoracom.com/ir/Quantumbiopha… Connect With AGORACOM Anyway You Like AGORACOM Website: https://www.agoracom.com – The Most Trusted Source Of Small Cap Information AGORACOM YouTube: Hit That Subscribe Button Right Now For More Powerful Videos AGORACOM X: https://www.x.com/AGORACOM Verified Top 0.2% Account AGORACOM Spotify: https://open.spotify.com/show/74mVPkf… Planes, Trains, Automobiles & Walking The Dog AGORACOM

Tags: , , , , ,
Posted in AGORACOM Via Satellite, Quantum BioPharma Ltd. | Comments Off on Canadian Small Cap Quantum BioPharma on The Verge of Multiple Sclerosis Breakthrough

Mining Legend Ewan Downie Leverages His Network & Success To Launch Giant Venture Capital

Posted by Brittany McNabb at 11:52 AM on Monday, January 27th, 2025

Ewan Downie’s career in the mining industry spans over 25 years, marked by remarkable success in company-building, major discoveries, and accretive acquisitions. As the former CEO of i-80 Gold Corp, President and CEO of Premier Gold Mines, and CEO of Wolfden Resources Corporation, Downie led these companies through transformative stages, culminating in high-value takeover transactions. Notably, he orchestrated the acquisition of the Hardrock gold project from Barrick Gold for just $3 million, a move that would later become the flagship asset for Equinox Gold.

In addition to his leadership roles, Downie was awarded the 2003 Bill Dennis Prospector of The Year by the PDAC for his major polymetallic base metal discovery in Canada, further cementing his reputation as one of the industry’s foremost visionaries.

TRANSITIONING TO VENTURE CAPITAL: GIANT VENTURE CAPITAL’S AMBITIOUS STRATEGY

Now, as the Principal at Giant Venture Capital, Downie is channeling his expertise into high-growth exploration opportunities. In this exclusive interview with AGORACOM Founder George Tsiolis, Downie shares how his extensive mining experience and success in acquisitions are informing his new venture, which aims to identify and develop undervalued grassroots projects with massive upside potential. Downie reveals that his team is already working on projects with mining giants like Glencore and is exploring new opportunities in Nevada and other high-potential jurisdictions.

STRATEGIC VISION FOR THE FUTURE OF EXPLORATION AND MINING CAPITAL

Giant Venture Capital’s strategy is simple but powerful: identify and develop undervalued, advanced grassroots projects with a clear path to commercialization. Downie’s team plans to launch one new company per year, with a strong focus on leveraging technological advances, including AI-driven exploration, to accelerate discovery and improve efficiency in the field.

ADDRESSING CHALLENGES IN CANADIAN MINING AND LOOKING AHEAD

During the conversation, Downie also discusses the challenges currently facing the Canadian mining sector, from regulatory hurdles to strained relations with First Nation communities. He advocates for a more business-friendly approach to permitting, which could unlock faster approvals and drive industry growth. Despite the sector’s cyclical challenges, Downie remains optimistic about the future of exploration and the potential for venture capital to play a transformative role.

THE ROAD AHEAD: A BRIGHT FUTURE FOR MINING EXPLORATION

Downie’s transition to venture capital is backed by his deep understanding of the mining sector, a proven ability to identify value, and a strategic vision that incorporates the latest technological advancements. As he continues to build Giant Venture Capital, he remains committed to discovering the next big mining opportunity—and investors with an eye on high-growth, long-term potential should keep a close watch on this evolving story.

Posted in AGORACOM Via Satellite | Comments Off on Mining Legend Ewan Downie Leverages His Network & Success To Launch Giant Venture Capital

Quantum BioPharma Sues CIBC, RBC & Others For $700 Million Alleging Spoofing/Short Selling Stock Manipulation

Posted by Brittany McNabb at 3:18 PM on Monday, November 18th, 2024

Quantum BioPharma (Formerly FSD Pharma) has filed a groundbreaking $700 million lawsuit against major Canadian banks, CIBC and RBC, alleging a scheme of stock price manipulation known as “spoofing.” CEO and Co-Chairman Zeeshan Saeed explains that this isn’t just a shot in the dark—industry experts estimate that damages could exceed $1 billion for $QNTM. 

The company’s legal team, confident in the strength of the case, has agreed to take it on a contingency basis, signaling their belief that this could be a watershed moment for both Quantum BioPharma and the entire small cap sector.

“Our goal is to seek justice for our shareholders and stop manipulative practices that hurt ordinary investors,” Saeed stated, underscoring the severity of the issue.

SPOOFING: A MARKET MANIPULATION TACTIC WITH HIGH STAKES

The crux of the lawsuit revolves around a deceptive trading tactic known as spoofing, where large orders are placed and then canceled to manipulate stock prices. According to Zeeshan, this method has been used by CIBC and other financial institutions to artificially drive down Quantum BioPharma’s share price, resulting in significant losses. This isn’t an isolated issue—similar market manipulation has been flagged by advocacy groups like Save Canadian Mining.

The case has been filed in the U.S. District Court for the Southern District of New York, a jurisdiction known for its expertise in financial offenses. Zeeshan emphasized the importance of this venue, noting that “the judges understand the nuances of these complex financial crimes.”

FIGHTING FOR SHAREHOLDERS

Beyond the financial toll, the impact on shareholder confidence has been severe. Zeeshan spoke candidly about the personal toll this manipulation has taken, including threats to his safety. Yet, he remains steadfast in his commitment to Quantum BioPharma’s future, outlining a strategy that could see the company investing in its pipeline and potentially issuing dividends to shareholders if the lawsuit is successful.

George and Zeeshan both drew comparisons to landmark legal battles like the Erin Brockovich case, illustrating how a small player can take on corporate giants and make a real difference.

If you enjoy David vs Goliath stories, watch or listen to this interview to see how this could transform Quantum BioPharma’s future and potentially end market manipulation in the small cap sector once and for all.

Tags: , , , , , ,
Posted in AGORACOM Via Satellite, Quantum BioPharma Ltd. | Comments Off on Quantum BioPharma Sues CIBC, RBC & Others For $700 Million Alleging Spoofing/Short Selling Stock Manipulation

Kidoz Generates $USD 1.79 Million In Q1 24 Revenue, Record Revenue Expected In ’24

Posted by Brittany McNabb at 4:44 PM on Thursday, May 30th, 2024

If you believe in the future of digital advertising and you should because 50% of TV advertising has shifted to digital and continues to accelerate, then you are going to love discovering Kidoz who is the absolute leader in child safe mobile advertising.   

Offering a secure platform for brands to engage with their target audience. This innovative approach has not only propelled Kidoz to the forefront of the adtech industry but has also revolutionized how brands connect with younger demographics in a safe and meaningful way.

Just How BIG Are We Talking?

Kidoz powers nearly 5,000 apps worldwide, reaching over 400 MILLION kids, teens, and families monthly.

Working With Top Brands

  • Disney
  • McDonald’s
  • Hasbro
  • Lego
  • Trusted Partner of Apple & Google

In the realm of mobile AdTech, Kidoz Inc. shines in Q1-2024. Despite market challenges, Q1 2024 revenues hit USD $1.79 million and recorded revenues of $13,326,824 in 2023

Financial Performance and Efficiency Improvements

Financially, Kidoz has shown phenomenal growth, with revenues rising from $1.9 million in 2017 to $13.3 million in 2023.

In Q1-2024, Kidoz saw a 7% revenue increase to nearly $1.8 million vs. Q1-23 revenue: $1.67M and a 43% rise in gross profit due to reduced operating expenses.

Significant cost efficiency was achieved in media costs, leading to improved profitability despite Q1 being the slowest quarter of the year.

Competitive Advantages in Mobile Gaming

Kidoz capitalizes on the shift from traditional TV to digital, specifically targeting kids on mobile games.

The platform provides interactive advertising opportunities, where users engage directly with ads, unlike passive viewing on YouTube.

With changes in tech privacy and cookie usage, Kidoz cookie-less, context-based approach offers a robust alternative, making it a strong competitor in the mobile gaming ad space.

Strategic Staffing and Partnerships

Kidoz expanded its workforce and forged seven new sales partnerships globally in 2023, aiming to enhance its market reach and operational capacity.

Comments From the CEO 

“We’re proud of the revenue growth and financial improvements achieved in Q1 2024″, stated Jason Williams, Kidoz CEO.  “The digital advertising landscape continues to evolve in 2024 with a transition from the heightened activity seen during the pandemic.  However, Kidoz has adapted its strategy and been successful refining our strategies to meet the changing market dynamics,” continued Williams.

Kidoz’s stellar Q1 2024 revenue and 2023 performance confirms its leadership in child-safe mobile advertising. Watch this compelling interview with Jason Williams, Kidoz Inc CEO. 

Tags: , , , , ,
Posted in AGORACOM Via Satellite, Kidoz | Comments Off on Kidoz Generates $USD 1.79 Million In Q1 24 Revenue, Record Revenue Expected In ’24

« Older Entries
Newer Entries »